Allecra's Exblifep Effective in Hospital-Based Urinary Tract Infections

Allecra Therapeutics, with locations in Saint-Louis, France and Weil, Am Rhein, Germany, indicated its Exblifep (cefepime-enmetazobactam) hit pre-specified primary endpoints in its Phase III ALLIUM clinical trial in complicated urinary tract infections (cUTI), including acute pyelonephritis (AP). It also demonstrated superiority over piperacillin-tazobactam.